Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esteban Celis

Showing results (31-40 of 121) with videos related to

Pageof 13
Sort By:
International Immunology|September 8, 2004
Antigen-independent acquisition of MHC class II molecules by human T lymphocytesAnita H Undale, Peter J van den Elsen, Esteban Celis
Blood|September 20, 2002
Creating space: an antigen-independent, CpG-induced peripheral expansion of naive and memory T lymphocytes in a full T-cell compartmentEduardo Davila, Maria G Velez, Carrie J Heppelmann, et al.
Cancer Research|March 11, 2017
Local Activation of p53 in the Tumor Microenvironment Overcomes Immune Suppression and Enhances Antitumor ImmunityGang Guo, Miao Yu, Wei Xiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Recognition of six-transmembrane epithelial antigen of the prostate-expressing tumor cells by peptide antigen-induced cytotoxic T lymphocytesDavid A Rodeberg, Rebecca A Nuss, Sherine F Elsawa, et al.
Cancer Research|February 28, 2012
A potent vaccination strategy that circumvents lymphodepletion for effective antitumor adoptive T-cell therapyHyun-Il Cho, Eduardo Reyes-Vargas, Julio C Delgado, et al.
Cancer Research|December 3, 2008
In vivo expansion, persistence, and function of peptide vaccine-induced CD8 T cells occur independently of CD4 T cellsDeepak Assudani, Hyun-Il Cho, Nicholas DeVito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Direct costimulation of tumor-reactive CTL by helper T cells potentiate their proliferation, survival, and effector functionRobert L Giuntoli, Jun Lu, Hiroya Kobayashi, et al.
Cancer Immunology, Immunotherapy : CII|April 20, 2005
Lack of effective T-lymphocyte response to the PAX3/FKHR translocation area in alveolar rhabdomyosarcomaDavid A Rodeberg, Rebecca A Nuss, Carrie J Heppelmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2002
Inhibition of EBV-induced lymphoproliferation by CD4(+) T cells specific for an MHC class II promiscuous epitopeRyusuke Omiya, Chantal Buteau, Hiroya Kobayashi, et al.
Cancer Immunology, Immunotherapy : CII|April 27, 2018
Role of MDA5 and interferon-I in dendritic cells for T cell expansion by anti-tumor peptide vaccines in miceHussein Sultan, Juan Wu, Takumi Kumai, et al.
Pageof 13

Showing results (31-40 of 121) with videos related to

Sort By:
Pageof 13
International Immunology|September 8, 2004
Antigen-independent acquisition of MHC class II molecules by human T lymphocytesAnita H Undale, Peter J van den Elsen, Esteban Celis
Blood|September 20, 2002
Creating space: an antigen-independent, CpG-induced peripheral expansion of naive and memory T lymphocytes in a full T-cell compartmentEduardo Davila, Maria G Velez, Carrie J Heppelmann, et al.
Cancer Research|March 11, 2017
Local Activation of p53 in the Tumor Microenvironment Overcomes Immune Suppression and Enhances Antitumor ImmunityGang Guo, Miao Yu, Wei Xiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Recognition of six-transmembrane epithelial antigen of the prostate-expressing tumor cells by peptide antigen-induced cytotoxic T lymphocytesDavid A Rodeberg, Rebecca A Nuss, Sherine F Elsawa, et al.
Cancer Research|February 28, 2012
A potent vaccination strategy that circumvents lymphodepletion for effective antitumor adoptive T-cell therapyHyun-Il Cho, Eduardo Reyes-Vargas, Julio C Delgado, et al.
Cancer Research|December 3, 2008
In vivo expansion, persistence, and function of peptide vaccine-induced CD8 T cells occur independently of CD4 T cellsDeepak Assudani, Hyun-Il Cho, Nicholas DeVito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Direct costimulation of tumor-reactive CTL by helper T cells potentiate their proliferation, survival, and effector functionRobert L Giuntoli, Jun Lu, Hiroya Kobayashi, et al.
Cancer Immunology, Immunotherapy : CII|April 20, 2005
Lack of effective T-lymphocyte response to the PAX3/FKHR translocation area in alveolar rhabdomyosarcomaDavid A Rodeberg, Rebecca A Nuss, Carrie J Heppelmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2002
Inhibition of EBV-induced lymphoproliferation by CD4(+) T cells specific for an MHC class II promiscuous epitopeRyusuke Omiya, Chantal Buteau, Hiroya Kobayashi, et al.
Cancer Immunology, Immunotherapy : CII|April 27, 2018
Role of MDA5 and interferon-I in dendritic cells for T cell expansion by anti-tumor peptide vaccines in miceHussein Sultan, Juan Wu, Takumi Kumai, et al.
Pageof 13